China's Shanghai Pharmaceuticals production volume 2021, by product
In 2021, Shanghai Pharmaceutical Group Co., Ltd. produced around 0.6 million pieces of polymyxin B sulfate for injection, one of the top products of the company. Its production and sales volumes both recorded a significant increase compared to the previous year. The enterprise is one of the largest national pharmaceutical groups in China which owns over 1,700 pharmacies.